Re:Elizabeth Holmes is on trial for fraud, but don't forget ...
by thehappypm on Friday October 22, 2021 @09:40AM
(#28957061)
I can't see how it was a con job. They were doing R&D. They were clearly trying to make the machines work and were just straight-up struggling with the tech.
Re:Elizabeth Holmes is on trial for fraud, but don't forget ...
by stevula on Friday October 22, 2021 @10:00AM
(#28957271)
The fact that the tech was not ready for production was hidden from investors and the public. They sold the tests in Walgreens to real patients, knowing the machines were not accurate.
Imagine the trauma of being diagnosed with a life-threatening disease, only to find out later that you’re fine. Or worse, a false negative result leading to a disease going undiscovered until it’s already progressed to a late stage.
Re:Elizabeth Holmes is on trial for fraud, but don't forget ...
by thehappypm on Friday October 22, 2021 @04:25PM
(#28962295)
That might make it fraudulent or negligent but a con is a very specific thing.
Re:Elizabeth Holmes is on trial for fraud, but don't forget ...
by Grustaf on Friday October 22, 2021 @09:46AM
(#28957128)
The con was that they claimed that they were working when they weren't. Clear as day.
Re:Elizabeth Holmes is on trial for fraud, but don't forget ...
by yesenadam on Friday October 22, 2021 @11:04AM
(#28958150)
(Not an expert at all, but have read Carreyrou's book.)
You make it sound like they were 80 or 90% of the way there. But it seems like what they promised—hundreds of tests from a drop of blood—is totally impossible, which is why it sounded so amazing. They were not even 1% of the way to what they were saying they already could do. And they were giving what sound like fairly random blood test results to people with serious medical conditions, while pretending they were 100% of the way there.
Theranos isn't a typical case of founder hype like you describe. It was a con job through and through.
Don't harbour sympathy for Holmes. She's made it harder for good-faith actors to get access to funding.